News

GSK Licenses Shigella Vaccine to Bharat Biotech
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...
GlaxoSmithKline Pharmaceuticals Shares Decline by 2.21% in Today's Trading
GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...
LBC4d
World-first 'Trojan horse' blood cancer drug given green light for NHS
Blood cancer patients in England will be the first in the world to be offered a 'Trojan horse' drug. Thousands of patients ...
‘Trojan horse’ treatment given green light for NHS use
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
NHS green lights ‘Trojan horse’ treatment that attacks cancer cells from inside
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
Drug Target Review5d
A spatial approach to understanding drug dynamics using mass spectrometry imaging
What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...
Explore more
Newseria BIZNES5d
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...